'Median survival' diaporamas de présentation

Therapeutic Hypothermia

Therapeutic Hypothermia. Joseph Foley 12-17-2009. Therapeutic Hypothermia. Background. Sudden Cardiac Death Estimated number of out-of-hospital SCD cases is 300,000 per yr in US Incidence anywhere from 35-125/100,000 people with 25% less than 65y/o Cobb JAMA 2002

2.37k views • 122 slides

Corporate Presentation

547 views • 43 slides

Oncology Board Review

790 views • 39 slides

Palliative Care in MiPCT : Extending the Continuum of Care

Palliative Care in MiPCT : Extending the Continuum of Care. Phil Rodgers, MD FAAHPM Associate Professor, Department of Family Medicine Associate Director for Clinical Programs, Palliative Medicine Program University of Michigan Health System MiPCT 2013 Annual Summit October 2013.

490 views • 37 slides

Lymphoma

Lymphoma. David Lee MD, FRCPC. Overview. Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma. Conceptualizing lymphoma. neoplasms of lymphoid origin, typically causing lymphadenopathy leukemia vs lymphoma

1.83k views • 36 slides

Rare Blood Disorder Initiative, Blood Surveillance Sept 30, 2006

Rare Blood Disorder Initiative, Blood Surveillance Sept 30, 2006. Bruce Ritchie Hematology, University of Alberta, Edmonton, Alberta. Disclosure. Honoraria: Bayer, Baxter, Sanofi, Astra-Zeneca, Novo-Nordisk, Aventis-Behring, ZLB, Pharmacia, Pfizer - all go towards studentships

505 views • 35 slides

Restrictive Cardiomyopathy

Restrictive Cardiomyopathy. Loryn S. Feinberg Wednesday, April 20, 2005 Echocardiography Conference. Restrictive Cardiomyopathy. Definition Characteristics Clinical Presentation Classification Specific Diseases & Echo Findings General Echo Features. Definition.

1.94k views • 34 slides

?? ??? ???? ????

?? ??? ???? ????. ???? ?????????. Cut points of OBESITY. Dr. Khalili PhD candidate in epidemiology Shahid beheshti university (MC). Some Points About Dichotomizing continuous predictors. Trade off. Simplicity & Practicality . Measurement error & low Power. We loss some information

652 views • 33 slides

Padova, 30 maggio 2008

522 views • 26 slides

Richa Manwani 9.11.2017

3 Clinical profiles and outcomes in 1203 newly diagnosed patients with systemic AL amyloidosis: first analysis of the ALchemy study. Richa Manwani 9.11.2017. Systemic AL amyloidosis. Mahmood et al, Haematologica 2014. Systemic AL Amyloidosis. Methods.

921 views • 23 slides

SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME

373 views • 22 slides

Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist

Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist . Hagop M. Kantarjian, MD Chairman; Professor, Department of Leukemia University of Texas, MD Anderson Cancer Center Houston, Texas Jorge E. Cortes, MD Chair, CML Section, Division of Cancer Medicine

307 views • 21 slides

Liver Transplantation for Hilar Cholangiocarcinoma

Liver Transplantation for Hilar Cholangiocarcinoma. Mary Douglas, RN, MSN,CCTC Clinical Transplant Coordinator University of Wisconsin- Madison. Case Study. 44 yo male with PSC/ UC. Dx with UC age 37, PSC at age 42 ERCP 5 years after diagnosis revealed adenocarcinoma via brushings

905 views • 18 slides

University of Catania

University of Catania. School of Medicine Department of Neurosciences Section of Neurosurgery. State of the art in microsurgery of Brain Gliomas. Vincenzo Albanese. Removal of right cerebral hemisphere for certain tumors with hemiplegia Dandy WE JAMA 90: 823-825, 1928 .

314 views • 18 slides

Treatment of Hormone-refractory Prostate Cancer

Treatment of Hormone-refractory Prostate Cancer. Sandra Kurtin, RN, MS, AOCN, ANP-C ? Hematology/Oncology Nurse Practitioner Arizona Cancer Center Clinical Assistant Professor of Nursing Clinical Assistant Professor of Medicine University of Arizona Tucson, AZ.

163 views • 15 slides

The Epidemiology of Idiopathic Pulmonary Fibrosis

The Epidemiology of Idiopathic Pulmonary Fibrosis. Vidya Navaratnam University of Nottingham. What is IPF?. Chronic, progressive, fibrotic lung disease of unknown aetiology More common in men Average age of presentation 71 years Median survival 3 years Lots of symptoms

454 views • 15 slides

CYSTIC FIBROSIS (CF)

CYSTIC FIBROSIS (CF). Symptoms. Incorrect folding of the the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein results in its destruction The cell membranes in epithelial cells of lungs, pancreas, colon and urinogenital tract lack chloride ion pores

222 views • 8 slides

Mental Status Changes

Mental Status Changes. History. 52 y o female presented to the ED with mental status changes Bradycardia noted in ED. Chest Radiograph. Chest CT. History. Lifelong nonsmoker Maternal history of emphysema Smoker Chronic daily cough No hemoptysis SOB with exertion No toxic exposure.

224 views • 7 slides

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter,

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial. Authors: Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group Reviewer: Dr. Chris Booth Date posted: December 12 2007.

222 views • 6 slides

Rikkunshito (1.0%) : 25 days (n=19) *

Median survival. Control : 23 days (n=20). Rikkunshito (0.5%) : 24 days (n=20). Rikkunshito (1.0%) : 25 days (n=19) *. 100. 80. 60. Survival rate (%). 40. 20. 0. 0. 2. 4. 6. 8. 10. 12. 14. 16. 18. 20. 22. 24. 26. 28. 30. Time after treatment (days).

146 views • 1 slides